4.5 Article

Therapeutics for mitochondrial dysfunction-linked diseases in Down syndrome

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Impaired Brain Mitochondrial Bioenergetics in the Ts65Dn Mouse Model of Down Syndrome Is Restored by Neonatal Treatment with the Polyphenol 7,8-Dihydroxyflavone

Daniela Valenti et al.

Summary: This study found that brain mitochondrial bioenergetic defects are present in Ts65Dn pups and early treatment with 7,8-DHF can positively impact mitochondrial function. These findings suggest the potential of 7,8-DHF as a translational treatment for neurodevelopmental alterations in Down syndrome.

ANTIOXIDANTS (2022)

Article Cell Biology

A Heme-Binding Transcription Factor BACH1 Regulates Lactate Catabolism Suggesting a Combined Therapy for Triple-Negative Breast Cancer

Joselyn Padilla et al.

Summary: BACH1 negatively regulates lactate catabolic pathways in TNBC cells, and its depletion increases sensitivity to MCT1 inhibition. Small inhibitory molecules better suppress the growth of BACH1-depleted TNBC cells.
Review Cell Biology

Triplication of HSA21 on alterations in structure and function of mitochondria

Bani Bandana Ganguly et al.

Summary: Gene triplication on human chromosome 21 is responsible for Down syndrome (DS) phenotypes, causing dosage imbalance in nuclear genes and mitochondrial DNA (mtDNA), affecting energy production, respiration, and redox homeostasis in cells. Cell tissues from DS patients and DS mouse models show elevated mtDNA numbers but reduced content due to increased fission process, impacting oxidative phosphorylation and cellular protection from toxic environments. The complex interplay between nuclear and mitochondrial genomes contributes to mitochondrial dysfunction, affecting organ function and promoting neurodegenerative diseases and cardiac complexities in individuals with DS.

MITOCHONDRION (2022)

Article Biochemistry & Molecular Biology

Down syndrome is an oxidative phosphorylation disorder

M. Pilar Bayona-Bafaluy et al.

Summary: Down syndrome is the most common genomic disorder of intellectual disability caused by trisomy of chromosome 21. Genes in this chromosome repress mitochondrial biogenesis, leading to a defect in oxidative phosphorylation as an early and general event in individuals with Down syndrome. Drugs that enhance mitochondrial biogenesis have been tested in mouse models, showing potential in restoring neurogenesis and cognitive defects associated with Down syndrome.

REDOX BIOLOGY (2021)

Review Biotechnology & Applied Microbiology

Natural products in drug discovery: advances and opportunities

Atanas G. Atanasov et al.

Summary: Natural products and their analogues have historically played a significant role in pharmacotherapy, however, they also present challenges. Recent technological and scientific developments are addressing these challenges and revitalizing interest in natural products as drug leads, particularly for combating antimicrobial resistance.

NATURE REVIEWS DRUG DISCOVERY (2021)

Article Multidisciplinary Sciences

The flavonoid 7,8-DHF fosters prenatal brain proliferation potency in a mouse model of Down syndrome

Fiorenza Stagni et al.

Summary: The study suggests that the use of 7,8-DHF can improve or restore overall brain proliferation potency in prenatal Ts65Dn mice, with mild long-term effects. However, further research is needed to determine if treatment can extend into the neonatal period to achieve sustained improvement in brain development in adulthood.

SCIENTIFIC REPORTS (2021)

Article Genetics & Heredity

Building the Future Therapies for Down Syndrome: The Third International Conference of the T21 Research Society

Mara Dierssen et al.

Summary: Research on Down syndrome has been increasing in recent years, with the Trisomy 21 Research Society being a leading scientific organization in this field. The Third International Conference of T21RS brought together scientists, families, and industry representatives to share discoveries on T21, including cognitive and behavioral challenges, comorbidities, and potential therapeutic approaches. This demonstrates a strong interest and ongoing advancement in understanding and treating conditions associated with T21.

MOLECULAR SYNDROMOLOGY (2021)

Article Biochemistry & Molecular Biology

Chemical reversal of abnormalities in cells carrying mitochondrial DNA mutations

Hiroki Kobayashi et al.

Summary: Mitochondrial DNA mutations cause mitochondrial diseases, leading to various phenotypic abnormalities in cells. A small-molecule compound called tryptolinamide (TLAM) was discovered to activate mitochondrial respiration and rescue defects in neuronal differentiation in iPSCs with a high ratio of mutant mtDNA by inhibiting PFK1 and promoting AMPK-mediated fatty-acid oxidation. TLAM redirects carbon flow from glycolysis to the pentose phosphate pathway to enhance anti-oxidative potential. These findings suggest that PFK1 could be a potential therapeutic target for mitochondrial diseases.

NATURE CHEMICAL BIOLOGY (2021)

Article Medicine, General & Internal

Down syndrome

Stylianos E. Antonarakis et al.

NATURE REVIEWS DISEASE PRIMERS (2020)

Review Biochemistry & Molecular Biology

Antioxidants in Down Syndrome: From Preclinical Studies to Clinical Trials

Noemi Rueda Revilla et al.

ANTIOXIDANTS (2020)

Article Genetics & Heredity

Apigenin as a Candidate Prenatal Treatment for Trisomy 21: Effects in Human Amniocytes and the Ts1Cje Mouse Model

Faycal Guedj et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2020)

Article Biochemistry & Molecular Biology

NRF2 and PPAR-gamma Pathways in Oligodendrocyte Progenitors: Focus on ROS Protection, Mitochondrial Biogenesis and Promotion of Cell Differentiation

Chiara De Nuccio et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Genetics & Heredity

Pioglitazone Improves Mitochondrial Organization and Bioenergetics in Down Syndrome Cells

Nunzia Mollo et al.

FRONTIERS IN GENETICS (2019)

Review Behavioral Sciences

Down syndrome: Neurobiological alterations and therapeutic targets

Rosa Anna Vacca et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2019)

Article Cell Biology

Luteolin induces hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome

Wen-Bo Zhou et al.

NEURAL REGENERATION RESEARCH (2019)

Article Cardiac & Cardiovascular Systems

Down Syndrome Critical Region 1 Gene, Rcan1, Helps Maintain a More Fused Mitochondrial Network

Valentina Parra et al.

CIRCULATION RESEARCH (2018)

Editorial Material Cardiac & Cardiovascular Systems

RCAN1-Calcineurin Axis and the Set-Point for Myocardial Damage During Ischemia-Reperfusion

J. Jose Corbalan et al.

CIRCULATION RESEARCH (2018)

Review Biochemistry & Molecular Biology

Mitochondria as pharmacological targets in Down syndrome

Daniela Valenti et al.

FREE RADICAL BIOLOGY AND MEDICINE (2018)

Review Chemistry, Medicinal

The critical role of epigallocatechin gallate in regulating mitochondrial metabolism

Weimei Shi et al.

FUTURE MEDICINAL CHEMISTRY (2018)

Review Medicine, Research & Experimental

Altered mitochondrial function in insulin-deficient and insulin-resistant states

Gregory N. Ruegsegger et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Article Biochemistry & Molecular Biology

Regulator of Calcineurin 1 helps coordinate whole-body metabolism and thermogenesis

David Rotter et al.

EMBO REPORTS (2018)

Article Multidisciplinary Sciences

In vivo modeling of human neuron dynamics and Down syndrome

Raquel Real et al.

SCIENCE (2018)

Review Geriatrics & Gerontology

Effects of acetyl-L-carnitine in diabetic neuropathy and other geriatric disorders

G. Sergi et al.

AGING CLINICAL AND EXPERIMENTAL RESEARCH (2018)

Review Genetics & Heredity

Down syndrome and the complexity of genome dosage imbalance

Stylianos E. Antonarakis

NATURE REVIEWS GENETICS (2017)

Article Biochemistry & Molecular Biology

Dimethyl fumarate mediates Nrf2-dependent mitochondrial biogenesis in mice and humans

Genki Hayashi et al.

HUMAN MOLECULAR GENETICS (2017)

Review Behavioral Sciences

Therapeutic role of sirtuins in neurodegenerative disease and their modulation by polyphenols

Marjan Ajami et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2017)

Review Cell Biology

Oxidative Stress: Harms and Benefits for Human Health

Gabriele Pizzino et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)

Review Pharmacology & Pharmacy

Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients

Masashi Asai et al.

YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN (2017)

Article Multidisciplinary Sciences

Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation

Kelly D. Sullivan et al.

SCIENTIFIC REPORTS (2017)

Review Cardiac & Cardiovascular Systems

Anthracycline-Related Cardiotoxicity in Patients with Acute Myeloid Leukemia and Down Syndrome: A Literature Review

Erik Hefti et al.

CARDIOVASCULAR TOXICOLOGY (2016)

Article Biochemistry & Molecular Biology

Synaptic dysfunction, memory deficits and hippocampal atrophy due to ablation of mitochondrial fission in adult forebrain neurons

B. Oettinghaus et al.

CELL DEATH AND DIFFERENTIATION (2016)

Article Endocrinology & Metabolism

Accuracy and precision of quantitative 31P-MRS measurements of human skeletal muscle mitochondrial function

Gwenael Layec et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2016)

Article Biochemistry & Molecular Biology

Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming

Michael D. Buck et al.

Article Biochemistry & Molecular Biology

Increased non-protein bound iron in Down syndrome: contribution to lipid peroxidation and cognitive decline

Caterina Manna et al.

FREE RADICAL RESEARCH (2016)

Article Biochemistry & Molecular Biology

The neurobiology of acetyl-L-carnitine

Giovanna Traina

FRONTIERS IN BIOSCIENCE-LANDMARK (2016)

Article Biochemistry & Molecular Biology

Global hypermethylation in fetal cortex of Down syndrome due to DNMT3L overexpression

Jie Lu et al.

HUMAN MOLECULAR GENETICS (2016)

Article Medicine, General & Internal

Protective effects of a natural product, curcumin, against amyloid β induced mitochondrial and synaptic toxicities in Alzheimer's disease

P. Hemachandra Reddy et al.

JOURNAL OF INVESTIGATIVE MEDICINE (2016)

Review Behavioral Sciences

Plant polyphenols as natural drugs for the management of Down syndrome and related disorders

Rosa Anna Vacca et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)

Article Chemistry, Medicinal

Exploring new ways of regulation by resveratrol involving miRNAs, with emphasis on inflammation

Norbert Latruffe et al.

RESVERATROL AND HEALTH (2015)

Review Chemistry, Medicinal

Longevity Pathways (mTOR, SIRT, Insulin/IGF-1) as Key Modulatory Targets on Aging and Neurodegeneration

Caio Henrique Mazucanti et al.

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2015)

Review Integrative & Complementary Medicine

Natural Compounds Modulating Mitochondrial Functions

Lara Gibellini et al.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2015)

Article Education, Special

Persistence of the benefit of an antioxidant therapy in children and teenagers with Down syndrome

Eduardo Benedetti Parisotto et al.

RESEARCH IN DEVELOPMENTAL DISABILITIES (2015)

Article Cardiac & Cardiovascular Systems

Loss of MicroRNA-155 Protects the Heart From Pathological Cardiac Hypertrophy

Hee Young Seok et al.

CIRCULATION RESEARCH (2014)

Review Obstetrics & Gynecology

Prenatal treatment of Down syndrome: a reality?

Faycal Guedj et al.

CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2014)

Article Nutrition & Dietetics

α-Tocopherol supplementation reduces biomarkers of oxidative stress in children with Down syndrome: a randomized controlled trial

S. Mustafa Nachvak et al.

EUROPEAN JOURNAL OF CLINICAL NUTRITION (2014)

Article Food Science & Technology

Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans

Rafael De la Torre et al.

MOLECULAR NUTRITION & FOOD RESEARCH (2014)

Article Education, Special

Antioxidant intervention attenuates oxidative stress in children and teenagers with Down syndrome

Eduardo Benedetti Parisotto et al.

RESEARCH IN DEVELOPMENTAL DISABILITIES (2014)

Article Cell Biology

Adaptive Downregulation of Mitochondrial Function in Down Syndrome

Pablo Helguera et al.

CELL METABOLISM (2013)

Article

Atypical aging in down syndrome

Warren B. Zigman

Developmental Disabilities Research Reviews (2013)

Article Multidisciplinary Sciences

Translating dosage compensation to trisomy 21

Jun Jiang et al.

NATURE (2013)

Article Physiology

Functional and biochemical characterization of soleus muscle in Down syndrome mice: insight into the muscle dysfunction seen in the human condition

Patrick M. Cowley et al.

AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2012)

Review Cardiac & Cardiovascular Systems

Mitochondria and Cardiovascular Aging

Dao-Fu Dai et al.

CIRCULATION RESEARCH (2012)

Article Geriatrics & Gerontology

Prolonged coenzyme Q10 treatment in Down syndrome patients, effect on DNA oxidation

Luca Tiano et al.

NEUROBIOLOGY OF AGING (2012)

Article Multidisciplinary Sciences

Luteolin Induces microRNA-132 Expression and Modulates Neurite Outgrowth in PC12 Cells

Lian-Fang Lin et al.

PLOS ONE (2012)

Review Cell Biology

Mitochondria in Apoptosis: Bcl-2 Family Members and Mitochondrial Dynamics

Jean-Claude Martinou et al.

DEVELOPMENTAL CELL (2011)

Article Biochemistry & Molecular Biology

α-Tocopherol suppresses lipid peroxidation and behavioral and cognitive impairments in the Ts65Dn mouse model of Down syndrome

Mototada Shichiri et al.

FREE RADICAL BIOLOGY AND MEDICINE (2011)

Article Genetics & Heredity

Genetic analysis of Down syndrome-associated heart defects in mice

Chunhong Liu et al.

HUMAN GENETICS (2011)

Article Biochemistry & Molecular Biology

Mitochondrial fission and remodelling contributes to muscle atrophy

Vanina Romanello et al.

EMBO JOURNAL (2010)

Article Agriculture, Multidisciplinary

Neurotrophic and Cytoprotective Action of Luteolin in PC12 Cells through ERK-Dependent Induction of Nrf2-Driven HO-1 Expression

Chia-Wei Lin et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2010)

Article Neurosciences

Systemic Mitochondrial Dysfunction and the Etiology of Alzheimer's Disease and Down Syndrome Dementia

Pinar E. Coskun et al.

JOURNAL OF ALZHEIMERS DISEASE (2010)

Article Multidisciplinary Sciences

A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone

Sung-Wuk Jang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Review Immunology

Intrinsic defect of the immune system in children with Down syndrome: a review

M. A. A. Kusters et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)

Article Geriatrics & Gerontology

Age-related muscle dysfunction

LaDora V. Thompson

EXPERIMENTAL GERONTOLOGY (2009)

Article Neurosciences

PPARγ stimulation promotes neurite outgrowth in SH-SY5Y human neuroblastoma cells

Gianluca Miglio et al.

NEUROSCIENCE LETTERS (2009)

Article Multidisciplinary Sciences

The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies

Jan O. Korbel et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Critical Care Medicine

Green tea catechin polyphenols attenuate behavioral and oxidative responses to intermittent hypoxia

Isabel C. Burckhardt et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)

Article Developmental Biology

Oxidative stress during diabetic pregnancy disrupts cardiac neural crest migration and causes outflow tract defects

Sarah C. Morgan et al.

BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY (2008)

Review Oncology

Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy

Yong Lin et al.

CURRENT CANCER DRUG TARGETS (2008)

Article Multidisciplinary Sciences

Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria

G. M. Cereghetti et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Genetics & Heredity

Classification of human chromosome 21 gene-expression variations in down syndrome:: Impact on disease phenotypes

E. Ait Yahya-Graison et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2007)

Article Public, Environmental & Occupational Health

The four ages of Down syndrome

Alan H. Bittles et al.

EUROPEAN JOURNAL OF PUBLIC HEALTH (2007)

Article Education, Special

The effect of acetyl-L-carnitine administration on persons with Down syndrome

Siegfried M. Pueschel

RESEARCH IN DEVELOPMENTAL DISABILITIES (2006)

Article Endocrinology & Metabolism

Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes

VB Ritov et al.

DIABETES (2005)

Article Multidisciplinary Sciences

Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication

PE Coskun et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Article Multidisciplinary Sciences

A chromosome 21 critical region does not cause specific down syndrome phenotypes

LE Olson et al.

SCIENCE (2004)

Article Biochemistry & Molecular Biology

Mitochondrial dysfunction and Down's syndrome

S Arbuzova et al.

BIOESSAYS (2002)